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perio-endo combined intrabony defectPlatelet-rich fibrin (PRF) is a second-generation platelet
concentrate that allows one to obtain fibrin membranes
enriched with platelets and growth factors from an
anticoagulant-free blood harvest.1 PRF can stimulate theFigure 1 Clinical photographs of the left anterior mandibular
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growth. The cell type-specific actions of PRF may be
beneficial for tissue regeneration.2 The present studysextant. (A) Initial photograph of #32. (B) Initial periapical
and one-wall combined with two-wall intrabony defect was
the middle part of the tube. The upper part contained acellular
ots were transformed into PRF box. (F) PRF membranes were
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Correspondence 463reported a patient with perio-endo combined intrabony
defect treated with PRF.
A 56-year-old man was referred to the Department of
Periodontics, Chung Shan Medical University Hospital, Tai-
chung, Taiwan, with a complaint of periodontal disease,
especially the left mandibular lateral incisor (#32) (Fig. 1A).
Accumulation of heavy plaque and calculus was noted, and
pus discharge from the pocket of #32 persisted. He had a
noncontributory medical history but had a smoking habit for
30 years. The periodontal examination revealed general
attachment loss and intrabony defect on #32, which showed
negative vitality (Fig. 1B). The treatment plan included
active periodontal therapy followed by supportive therapy,
smoking cessation, and endodontic treatment of #32. The
results of reevaluation showed overall probing depth
reduction; however, pus discharge from #32 continued. The
papilla preservation technique was done to reveal the
combination of one-wall and two-wall defects (Fig. 1C).
This was followed by thorough root debridement and
removal of granulation tissue, then a detoxified procedure
was performed with tetracycline. Blood samples were
taken according to the PRF protocol,2 with a PC-02 table
centrifuge and collection kits provided by Process (Nice,
France). Quickly, blood samples were taken from this pa-
tient without using an anticoagulant and placed into 10-mL
glass-coated plastic tubes (Vacutainer; Becton, Dickinson
and Company, Franklin Lakes, NJ, USA), which were
immediately centrifuged at 3000 rpm for 12 minutes. After
centrifugation, each PRF clot was separated from the red
blood cell base, condensed, and then modeled on a sterile
metal plate to obtain the PRF membranes (Figs. 1DeF). The
minced PRF graft materials mixed with b-tricalcium phos-
phate (Osteocera, Wiltron Co., Ltd, Hsinchu, Taiwan) were
filled in the defect. The PRF membrane was trimmed and
adapted over the grafted defect. A primary closure was
attempted and achieved by internal vertical mattress and
single suture with 4e0 Nylon. Wire splinting was done for
stabilization. Clinical healing was uneventful, with neither
infectious episodes nor untoward clinical symptoms. The
periapical radiography exhibited that the defect was filled
with bone-like dense tissue gradually (Figs. 1G and 1H). Six
months after the treatment, the thickness of the gingiva
increased on the buccal side approximately up to 1.5 mm
(Fig. 1I).
PRF is derived from an autogenous preparation of
concentrated platelets without any manipulation. The
clinical applications of PRF with or without graft have been
described in periodontal regeneration surgery,3 radicular
cyst enucleation,4 and gingival recession augmentation5 for
increasing hard and soft tissue regeneration. To the best ofour knowledge, this is the first report about the use of PRF
and b-tricalcium phosphate for treatment of perio-endo
combined intrabony defect. The results demonstrated the
achievement of probing depth reduction, clinical attach-
ment gain, increase of gingival thickness, and increase of
periapical bone density over a 6-month period. However,
more expanded clinical studies are needed to confirm these
findings.
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